Suzu Shinya

Suzu Shinya | Suzu Shinya

Homepage URL (1)： https://suzulab.wixsite.com/suzulab

Research keywords (1)： T細胞

Research theme for competitive and other funds (9)：

2023 - 2026 新規宿主因子M-SecがHIV-1とHTLV-1の伝播を促進する機構とその意義
2020 - 2023 HIV-1潜伏感染におけるfibrocytesおよびマクロファージの意義の解明
2018 - 2020 Establishment of a novel anti-HIV strategy targeting membranous nanotubes
2017 - 2020 Characterization of HIV-1 latently-infected fibrocytes
2018 - 2020 真のHIVリザーバーの同定と排除を目指した研究

Show all

Papers (94)：

Shukang Zhao, Lianbo Li, Yoshihiro Komohara, Eri Matsubara, Yusuke Shinchi, Ahmad Adawy, Hiromu Yano, Cheng Pan, Yukio Fujiwara, Koei Ikeda, et al. IL-32 production from lung adenocarcinoma cells is potentially involved in immunosuppressive microenvironment. Medical molecular morphology. 2024
Toshiki Anami, Cheng Pan, Yukio Fujiwara, Yoshihiro Komohara, Hiromu Yano, Yoichi Saito, Masamichi Sugimoto, Daiko Wakita, Takanobu Motoshima, Yoji Murakami, et al. Dysfunction of sinus macrophages in tumor-bearing host induces resistance to immunotherapy. Cancer Science. 2023
Ahmad Adawy, Lianbo Li, Hiroki Hirao, Tomoaki Irie, Daiki Yoshii, Hiromu Yano, Yukio Fujiwara, Shigeyuki Esumi, Masaki Honda, Shinya Suzu, et al. Potential involvement of IL-32 in cell-to-cell communication between macrophages and hepatoblastoma. Pediatric surgery international. 2023. 39. 1. 275-275
Youssef M Eltalkhawy, Naofumi Takahashi, Yasuo Ariumi, Jun Shimizu, Kazuo Miyazaki, Satoru Senju, Shinya Suzu. iPS cell-derived model to study the interaction between tissue macrophage and HIV-1. Journal of leukocyte biology. 2023
Hesham Nasser, Naofumi Takahashi, Youssef M Eltalkhawy, Omnia Reda, Sameh Lotfi, Kanako Nasu, Jun-Ichi Sakuragi, Shinya Suzu. Inhibitory and Stimulatory Effects of IL-32 on HIV-1 Infection. Journal of immunology (Baltimore, Md. : 1950). 2022. 209. 5. 970-978

ｍore...

MISC (7)：

菰原義弘, 野依修, 鈴伸也, 野坂生郷, 松岡雅雄. ATLLにおけるM-CSFR発現とM-CSFR阻害剤の有効性. 日本リンパ網内系学会会誌. 2019. 59. 118-118
前川隆彰, 大澤有紀子, 曽根岳大, 高田耕平, 小縣開, 齋藤啓太, 和泉拓野, 長尾茂輝, 高野昂佑, 岡田陽介, et al. Elotuzumab(抗SLAMF7抗体)のfibrocyte分化抑制作用と骨髄線維症治療薬としての可能性(Elotuzumab suppresses fibrocyte differentiation as a potent therapeutic agent for myelofibrosis). 臨床血液. 2018. 59. 9. 1527-1527
日吉真照, 鈴伸也, 岡田誠治. 【RIの逆襲アイソトープを活用した簡単・安全バイオ実験】基礎編核酸のRI標識法. 細胞工学. 2007. 別冊. RIの逆襲. 38-45
日吉真照, 鈴伸也, 岡田誠治. RIの逆襲意外と使えるアイソトープ核酸のRI標識法. 細胞工学. 2006. 25. 8. 932-939
原田英樹, 後藤優美, 高田比呂志, 鈴伸也, 滝口雅文, 岡田誠治. 新規免疫不全マウスNOD/SCID/Jak3-/-マウスにおけるヒトT細胞の再構築. 日本エイズ学会誌. 2005. 7. 4. 462-462

ｍore...

Books (4)：

Professional career (1)：

Work history (4)：

※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page